UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000008465
Receipt number R000009814
Scientific Title PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancer
Date of disclosure of the study information 2012/07/18
Last modified on 2018/07/13 10:20:24

No. Disposal Last modified on Item of update
1 Insert 2012/07/18 15:15:14
2 Update 2014/01/18 19:34:05 TEL
Email
Address
Address
TEL
Email
Email
3 Update 2018/07/13 10:09:57 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
4 Update 2018/07/13 10:17:28 Division name
Division name
Address
Email
Division name
Division name
Address
Email
Division name
Division name
Address
Email
Name of primary person or sponsor
Organization
Email1
5 Update 2018/07/13 10:20:24 Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria